Exelixis, Inc. (EXEL)
43.63
-0.53
(-1.20%)
USD |
NASDAQ |
Feb 20, 16:00
43.70
+0.07
(+0.16%)
After-Hours: 20:00
Exelixis Market Cap : 11.33B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 29.58B |
| Merck & Co., Inc. | 303.45B |
| Gilead Sciences, Inc. | 187.84B |
| Axsome Therapeutics, Inc. | 9.262B |
| Castle Biosciences, Inc. | 852.60M |
Market Cap Related Metrics
| PE Ratio | 15.67 |
| PS Ratio | 5.300 |
| PEG Ratio | 0.2747 |
| Price to Book Value | 5.243 |
| Price to Free Cash Flow | 14.04 |
| Price | 43.63 |
| Earnings Yield | 6.38% |
| PEGY Ratio | 0.2747 |
| Operating PE Ratio | 13.78 |
| Normalized PE Ratio | 15.39 |